Skip to main content
. 2017 Dec 4;15:245. doi: 10.1186/s12967-017-1350-1

Table 2.

TGF-β isoforms across CFS patients (including Fukuda and Canada 2003-subgroups) and healthy controls

CFS patients (n = 120) p valuea Healthy controls (n = 68) CFS, Fukuda subgroup (n = 88) p valuea CFS, Canada 2003 subgroup (n = 46) p valuea
Plasma TGF-β1 (pg/ml)
Median, IQR
4927 5157 0.482 5692 6350 4944 4276 0.599 4880 6247 0.831
Plasma TGF-β2 (pg/ml)
Mean, SD
758 262 0.928 754 278 712 246 0.809 780 252 0.621
Plasma TGF-β3 (pg/ml)
Median, IQR
230 227 0.901 251 250 230 208 0.990 243 254 0.760

TGF transforming growth factor beta, SD standard deviation, IQR interquartile range

aCompared with healthy controls. Statistical comparisons across groups are based upon Independent sample t test or Mann–Whitney test as appropriate